Ranked #5 CHU in France, the hospital combines research dynamics, innovation, and care quality. A springboard into tomorrow’s medicine, the CHU helps make Montpellier Métropole an area for excellence in health as well as company and job creation.
Assisting innovationWidely recognized for its training, the Montpellier CHU university hospital attracts increasing numbers of interns while also establishing other ties.
The Montpellier establishment was the first CHU to invest in a startup, MedXCell, which will set up its production center in Montpellier after its initial phase at the Cyborg bio-incubator.
“Imagining career paths for researchers and clinical practitioners that include founding a company seems like a good development model for the future", says Thomas Le Ludec.
This led to the creation of an “innovation extractor”, with 40,000 euros in co-funding by Montpellier Méditerranée Métropole. Since 2017, this program has analyzed 70 projects seeking to create or fine-tune processes for better prevention, care, management, and organization. Two startups have been founded. Two others will be launched soon and three are being assisted by Montpellier BIC.
In Thomas Le Ludec’s opinion, one piece was still missing: “detecting emerging ideas within our departments before they are picked up by the industry without generating any value for the CHU.”
“ We are not working to replace our ecosystem, but rather to work closely with it.”